Intrinsic Value of S&P & Nasdaq Contact Us

SpringWorks Therapeutics, Inc. SWTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$62.50
+33%

Stock Statistics — SWTX

SpringWorks Therapeutics, Inc. (SWTX) has a market capitalization of $3.54B and trades at $46.99. The 52-week range is 28.21-62.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13.5, Earnings Per Share (EPS) of $-3.48, annual revenue of $191.59M.

The stock has a beta of 0.70, operates in the Healthcare sector.

Trading Data
Current Price$46.99
52-Week Range28.21-62
Volume5.01M
Avg Volume (30D)5.85M
Market Cap$3.54B
Beta (1Y)0.70
Company
IPO Date2019-09-13
Employees368
CEOSaqib Islam
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS85205L1070
CUSIP85205L107
Income (Latest Year)
Revenue$191.59M
Gross Profit$179.04M
EBITDA$-278.13M
Operating Income$-278.13M
Net Income$-258.13M
EPS$-3.48
EPS Diluted$-3.48
Shares Outstanding$74.13M
Balance Sheet (Latest Year)
Total Assets$587.28M
Current Assets$380.47M
Cash & ST Investments$307.99M
Total Liabilities$106.17M
Total Debt$7.91M
Net Debt$-61.84M
Total Equity$481.1M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-13.5
P/S Ratio18.48
P/B Ratio7.36
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message